Morales A
Natl Cancer Inst Monogr. 1978 Dec(49):315-9.
The use of BCG as an intracavitary form of immunotherapy in human bladder cancers is discussed. The result of a clinical trial in which BCG is administered in the treatment of human bladder cancers is reported. Possible uses of this tumor model in the study of immunotherapy employing BCG are suggested.
本文讨论了卡介苗作为人类膀胱癌腔内免疫疗法的应用。报告了一项使用卡介苗治疗人类膀胱癌的临床试验结果。还提出了该肿瘤模型在卡介苗免疫治疗研究中的可能用途。